Effectiveness and Feasibility of Delivering an Education Program to Patients With an Acute Exacerbation of COPD
- Conditions
- Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
- Interventions
- Other: Introductory Disease Education
- Registration Number
- NCT02321215
- Lead Sponsor
- West Park Healthcare Centre
- Brief Summary
The purpose of this study is to determine if it is effective and feasible to provide a chronic obstructive pulmonary disease (COPD) education program to patients admitted with an acute exacerbation of COPD.
- Detailed Description
Following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) evidence strongly suggests that all patients should be discharged with an action plan, consisting of identified patient responsibilities for their ongoing care and advice on recognizing and seeking help in the event of future acute exacerbations. Despite these recommendations, structured chronic obstructive pulmonary disease (COPD) specific education is rarely offered within acute hospital settings and, in addition, research in this area is limited. This study aims to determine the effectiveness and feasibility of an introductory education program delivered during and shortly after an AECOPD hospitalization.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 31
- medically confirmed diagnosis of AECOPD (alone or combined with other conditions)
- capable of understanding the study information and giving informed consent
- admitted due to lung diseases other than COPD
- received COPD education in the previous 6 months (in primary care, acute or rehabilitation hospitals)
- presence of diagnosis of dementia or incapacity to learn due to cognitive issues
- have medical, cognitive or language limitations to communicating in written or spoken English
- have participated or been asked to participate in the trial before
- in the intensive care unit
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Education Intervention Introductory Disease Education Introductory disease education: This group will attend two one-on-one education sessions. The educational content will be standardized and a checklist will be used to ensure that all topics are addressed. The sessions will focus on enhancing self-efficacy in areas that are thought to be important to individuals who recently had an AECOPD.
- Primary Outcome Measures
Name Time Method Change from baseline in disease specific knowledge This primary outcome measure will be collected prior to randomization and approximately four weeks after admission Bristol COPD Knowledge Questionnaire (BCKQ)
Change from baseline in information needs This primary outcome measure will be collected prior to randomization and approximately four weeks after admission Lung Information Needs Questionnaire (LINQ)
- Secondary Outcome Measures
Name Time Method Feasibility measure: number of eligible patients This outcome variable will be noted within 1-2 days of hospital admission with an AECOPD (when determining patient eligibility, before randomization). Feasibility measure: ease of recruiting patients This outcome variable will be noted within 1-2 days of hospitalization, while the patient is being recruited (before randomization). Questions: (1) Is it easy to locate the patient in their room? (Yes/No) (2) How many times did the RA try to find the patient in the room before successfully finding them there? (#) (3) Does the patient have enough time to meet with the RA? (Yes/No)
Feasibility measure: compliance to the sessions This outcome measure will be noted after each education session. The education sessions will take place between 3-15 days after hospital admission for an AECOPD. Two education sessions will be delivered to every patient enrolled in the intervention arm. Questions: (1) Is the participant able to complete the half-hour session? (Yes/No) (2) How many times was the education session interrupted for any reason? (#)
Feasibility measure: follow-up rates This outcome variable will be noted between days 20-30 following admission to hospital (approximately four weeks after hospital admission). Proportion of subjects that complete the follow up stage (questionnaire responses)
Trial Locations
- Locations (1)
Humber River Hospital
🇨🇦Toronto, Ontario, Canada